Delivery Order SPE2DB20D1047-SPE2DB24FF40D
Award Date 1/24/24
Potential Completion Date 1/25/24
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,283,461 units of Lidocaine 5% Patch 30s. The $1,363.68 delivery order was placed under an existing contract and has a performance completion date of January 10, 2024. Amerisourcebergen Drug Corp is a prime contractor that has received numerous awards from DLA to supply pharmaceuticals, medical supplies, and related...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $2,709.61 to Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distributor Amerisourcebergen Corporation. The contract is for the provision of 4,564,340,251 units of Lidocaine 5% Patch 30s, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen Drug Corp, valued up to $999,999,999.00 through...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,144,138 units of Lidocaine 5% Patch 30s. The order has a potential value of $4,128.51 and a completion date of December 20, 2023. Amerisourcebergen Drug Corp, through its Corporate Office division, is a prime contractor that provides pharmaceutical products and services to U.S. government agencies, including the Department...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,416,774 units of Lidocaine 5% Patch 30s. The contract has a potential value of $1,178.60 and a completion date of January 24, 2024. No set-aside designation was used for this award. Amerisourcebergen Drug Corp, through its Corporate Office division, has received numerous federal contract awards to supply...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,243.20 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the delivery of 4,564,118,890 units of Lidocaine 5% Patch 30s, a specialty pharmaceutical product, with a period of performance through April 1, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA, valued at up to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,239,630 units of Lidocaine 5% Patches. The $1,097.36 award has a completion date of January 5, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp, as a prime contractor, has a history of supplying pharmaceuticals, medical supplies, and distribution services to support DLA Troop Support Medical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,107,006 units of Lidocaine 5% Patch 30s. The $1,808.79 contract has a performance period through March 29, 2024 and does not contain a set-aside designation. AmerisourceBergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 through December 31,...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,236,686 units of Lidocaine 5% Patch 30S. The total potential value of this delivery order is $1,910.04, with a completion date of January 5, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, has a history of providing pharmaceutical products and services to U.S. government agencies, primarily the...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $3,148.64 to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The order is for the supply of 4557487381 - Lidocaine 5% Patch 30s, a medical product. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that DLA awarded solely to Amerisourcebergen Drug Corp to provide a comprehensive...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The $8,238.39 firm-fixed-price contract is for the delivery of 4,564,160,115 units of Lidocaine 5% Patch 30s, with a completion date of April 4, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as...
- SPE2DB20D1047Indefinite Delivery Contract
- SPE2DB20D1047-SPE2DB24FF40DDelivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,428,053 units of Lidocaine 5% Patch 30s. The potential value of the award is $10,922.66, with a completion date of January 25, 2024. Amerisourcebergen Drug Corp, a for-profit organization, has previously received numerous federal contract awards from DLA to provide a range of pharmaceutical products and medical supplies in support of Defense Logistics Agency programs. This specific delivery order does not have a set-aside designation.
Generated 4/24/24, 1:02 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.9k | 1/24/24 |